logo
Sunderland surgeon who started as hospital porter retires

Sunderland surgeon who started as hospital porter retires

BBC News19-07-2025
A surgeon who started his NHS career as a hospital porter has retired after more than 40 years.Ben Banerjee first signed up to help patients in 1982 when he started work at Sunderland Royal Hospital.He has now stepped down from his role as a consultant vascular surgeon with South Tyneside and Sunderland NHS Foundation Trust.Paying tribute, the organisation said Mr Banerjee, who also completed his training at hospital in Newcastle before returning to Sunderland in 2004, had cared for thousands of patients.
As well as celebrating his retirement, Mr Banerjee has also been presented with an honorary doctorate of medicine by the University of Sunderland.It recognises his services to the city, the NHS and the military having joined the Army Reserves while he was a medical student.He was later deployed to Iraq, Bosnia, Kosovo and Afghanistan and was appointed as one of the Queen's honorary surgeons in 2019.He remains an honorary clinical senior lecturer in vascular surgery at Newcastle University.
Easington-born Mr Banerjee thanked the health trust for his surgery career and also for facilitating his military deployments.He said: "I have thoroughly enjoyed my time here at the trust, serving the people of Sunderland to the best of my ability in the NHS and the Army."I leave behind a fantastic team everywhere in this hospital, all of whom have supported me in some way over the years."The trust's executive medical director, Dr Shaz Wahid, said Mr Banerjee had "helped care for thousands of patients" and "used his expertise to not only treat those we look after, but share his knowledge with his colleagues"."His achievements through the Army are also a testament to his dedication to helping others and he is to be congratulated for the distinctions he has earned," Dr Wahid said.
Follow BBC Sunderland on X, Facebook, Nextdoor and Instagram.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NHS Lanarkshire first Scots health board to appoint permanent Promise Development Officer
NHS Lanarkshire first Scots health board to appoint permanent Promise Development Officer

Daily Record

time22 minutes ago

  • Daily Record

NHS Lanarkshire first Scots health board to appoint permanent Promise Development Officer

Beth-Anne McDowall has joined the organisation, which is committed to ensuring that all care-experienced people have the support they need if they have healthcare needs. NHS Lanarkshire is the first health board in Scotland to have a permanent Promise Development Officer. ‌ Beth-Anne McDowall has joined the organisation, which is committed to ensuring that all care-experienced people have the support they need if they have healthcare needs. ‌ Beth-Anne's role is to support NHS Lanarkshire to keep The Promise, through continuously learning about what creates change, and helping changes to be implemented. ‌ This includes ensuring that healthcare staff can provide the support children and young people in the care system need to grow up loved, safe and respected. It also applies to adults who have experienced the care system. Beth-Anne said: "This is the first Promise-centric post in an NHS health board. "My role will involve many things, for me, the primary function of my role is to ensure care-experienced people within Lanarkshire contribute, design, influence and shape the services they receive from us to ensure they meet their needs and that they are supported to thrive. "Keeping The Promise is everyone's responsibility, not just social work or a local authority. ‌ "This specific post demonstrates NHS Lanarkshire's commitment that all care-experienced people grow up loved, safe and respected, so that they can realise their full potential. "It is also a concrete commitment given as not only have NHS Lanarkshire created this post, they have made it permanent, ensuring that we will continuously adapt and evolve as the needs of the care community change. "It is fitting that I have been successful in securing the post given that I not only worked at The Independent Care Review to help shape the conclusions of The Promise, and in various other national roles but I, myself, am care-experienced and from Lanarkshire so I'm really attuned to the needs of the care community." ‌ Trudi Marshall, executive nurse director, added: "We are delighted to welcome Beth-Anne to NHS Lanarkshire. "The introduction of this post demonstrates our commitment to ensuring that the children and young people in Lanarkshire who have experienced care are supported to realise their full potential and that they grow up loved, safe and respected. "Working in collaboration with our local councils and health and social care partnerships we have already made significant progress in implementation of The Promise. ‌ "Beth-Anne will now support us to continue this work and ensure that we keep the voice of the community central to our work in NHS Lanarkshire." Beth-Anne brings a wealth of experience to this role. Not only has she experienced the care system first hand, she has been championing the rights of care-experienced children and adults for more than 10 years. ‌ She has worked on the front lines in local government and a national children's charity. Her outstanding contributions earned her a YouthLink Scotland Award in 2018 and a YoungScot Award in 2022. Remarkably, Beth-Anne became Scotland's youngest non-executive director at just 19, serving on the Children's Hearings Scotland board for over eight years and is now a board member with the Mental Welfare Commission.

How to switch from Mounjaro to Wegovy WITHOUT risking weight gain, reveals top GP - as 'King Kong' jab is set to TRIPLE in price
How to switch from Mounjaro to Wegovy WITHOUT risking weight gain, reveals top GP - as 'King Kong' jab is set to TRIPLE in price

Daily Mail​

time23 minutes ago

  • Daily Mail​

How to switch from Mounjaro to Wegovy WITHOUT risking weight gain, reveals top GP - as 'King Kong' jab is set to TRIPLE in price

A leading GP has issued guidance to patients on how to safely switch between weight loss drugs—as prices of the popular jab Mounjaro are set to soar. Dr Donald Grant, GP and Senior Clinical Advisor at The Independent Pharmacy, warned it is 'crucial' to transition under medical supervision in order to limit severe side effects and weight gain. His statement comes as CheqUp, one of the UK's largest providers of weight-loss treatments, reports sales of rival treatment Wegovy have jumped by more than 500 per cent in recent days as patients seek alternatives. Dr Donald Grant, GP and Senior Clinical Advisor at The Independent Pharmacy, said: 'As people consider potentially swapping Mounjaro for Wegovy, it's essential to understand the safe ways of transitioning between these two treatments. 'This can limit drastic side effects and avoid progress from plateauing.' 'It's crucial for people on these treatments to maintain open and honest conversations with their prescribing clinician or GP, who can provide tailored advice based on medical history and prior doses. 'You can't make a direct 'mg-for-mg' switch between Mounjaro and Wegovy because they are different drugs with different strengths. 'Instead, a medical professional will take a dose conversion approach, and if you make the decision to move, they will support you through this.' Mounjaro price increases Mounjaro®▼ (tirzepatide) KwikPen® Dose Current UK List Price New UK List Price (From September) 2.5mg £92 £133 5mg £92 £180 7.5mg £107 £255 10mg £107 £255 12.5mg £122 £330 15mg £122 £330 Earlier this month, Eli Lilly confirmed that the price of its blockbuster weight-loss jab Mounjaro will rise steeply for British patients from September 1. The drug, which is prescribed to around 90 per cent of people in the UK using weight-loss injections, will see the cost of its highest dose, 15mg, soar from £122 to £330 a month—a 170 per cent increase. Even mid-range doses such as the 5mg pen will jump from about £92 to £180, with an average rise across the range of 126 per cent. In the UK private market, Wegovy is generally cheaper. A 2.4 mg maintenance dose of Wegovy costs around £250 to £300 per month. At the lower end, Wegovy's starter dose is priced around £120 to £170. In clinical trials, Mounjaro has been shown to deliver the greatest weight loss of any licensed drug, with patients losing on average up to 22.5 per cent of their body weight over 72 weeks at the highest dose. By comparison, Wegovy patients lose up to 17.5 per cent over the same period on the full 2.4mg dose. Toby Nicol, CEO at CheqUp, said: 'As news of the Mounjaro price rise spreads, weight loss jab patients are voting with their wallets and making the switch to Wegovy, which is nearly as effective but has a considerably lower cost. 'We've been blown away by the huge spike in demand for Wegovy. It is too early to say for sure, but Wegovy will probably become the most popular weight loss treatment in the UK as patients switch from Mounjaro.' Superintendent Pharmacist Aaron Arman also stressed the importance of proper medical oversight: 'Both Mounjaro and Wegovy work in similar ways and are proven to be highly effective. 'For patients unable to afford the increase in price, it is possible to switch from Mounjaro to Wegovy, though the dose they can switch to will depend on the Mounjaro dose they are currently on.' CheqUp's research found as many as 80 per cent of current Mounjaro users will either switch or come off the drug entirely—an estimated 625,000 patients—while more than 325,000 say they have been priced out of treatment. Nicol added: 'A huge number of people will be considering switching and it's important they know that while this is absolutely possible, doing so under the supervision of a trusted pharmacist is a must. 'Simply stopping one treatment and moving to the other without due care can have serious health consequences.' Concerns are also mounting that so-called 'cowboy' operators will exploit the situation. Nicol warned: 'Black markets are going to try and exploit this situation. 'Go on any social media site and you can find cowboy operators in minutes—drug dealers, for all intents and purposes—taking advantage of confused patients who can no longer afford treatment but want to continue. As with most things in life, if it's too good to be true, it probably is.'

Palestine: Injured children could come to NI for treatment
Palestine: Injured children could come to NI for treatment

BBC News

time2 hours ago

  • BBC News

Palestine: Injured children could come to NI for treatment

Stormont's first and deputy first ministers are "close" to an agreement on allowing urgent medical treatment for children from Gaza as part of a UK-wide is understood that Michelle O'Neill and Emma Little-Pengelly are finalising plans by way of "urgent procedure" to enable Northern Ireland's participation in the scheme.A Stormont source told BBC News NI that a "very modest number" of children - possibly two or three - would be brought to NI under the medical could be among a group of between 30 and 50 critically ill and injured Palestinian children who are expected to be evacuated from Gaza to the UK for medical treatment in the coming weeks. The story was first reported in the Irish Minister Mike Nesbitt had previously expressed his support for the urgent procedure mechanism would mean the plan is not required to go to the whole executive for Executive Office and the Department of Health have both been contacted for comment.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store